118 related articles for article (PubMed ID: 1837511)
1. Impaired glucose tolerance is characterized by multiple abnormalities in the regulation of intermediary metabolism.
Krentz AJ; Singh BM; Nattrass M
Diabet Med; 1991 Nov; 8(9):848-54. PubMed ID: 1837511
[TBL] [Abstract][Full Text] [Related]
2. Effect of obesity on circulating intermediary metabolite concentrations in the absence of impaired glucose tolerance.
Robertson DA; Singh BM; Nattrass M
Int J Obes; 1991 Oct; 15(10):635-45. PubMed ID: 1752724
[TBL] [Abstract][Full Text] [Related]
3. Basal intermediary metabolism in impaired glucose tolerance and morbid obesity.
Krentz AJ; Singh BM; Hale PJ; Robertson DA; Nattrass M
Diabetes Res; 1992; 20(3):51-60. PubMed ID: 1345002
[TBL] [Abstract][Full Text] [Related]
4. Abnormal regulation of carbohydrate metabolism in motor neurone disease.
Krentz AJ; Williams AC; Nattrass M
Diabetes Res; 1991 Feb; 16(2):93-9. PubMed ID: 1817811
[TBL] [Abstract][Full Text] [Related]
5. Insulin resistance in the regulation of lipolysis and ketone body metabolism in non-insulin dependent diabetes is apparent at very low insulin concentrations.
Singh BM; Krentz AJ; Nattrass M
Diabetes Res Clin Pract; 1993 Apr; 20(1):55-62. PubMed ID: 8344130
[TBL] [Abstract][Full Text] [Related]
6. Metabolic abnormalities in obese patients with impaired glucose tolerance.
Robertson DA; Singh BM; Baddeley RM; Nattrass M
Diabet Med; 1990 Jan; 7(1):45-9. PubMed ID: 2137062
[TBL] [Abstract][Full Text] [Related]
7. Abnormal regulation of intermediary metabolism after oral glucose ingestion in myotonic dystrophy.
Krentz AJ; Coles NH; Williams AC; Nattrass M
Metabolism; 1990 Sep; 39(9):938-42. PubMed ID: 2202885
[TBL] [Abstract][Full Text] [Related]
8. Impaired glucose tolerance in obesity is associated with insensitivity to insulin in multiple aspects of metabolism as assessed by a low dose incremental insulin infusion technique.
Robertson DA; Singh BM; Nattrass M
Diabet Med; 1991 Oct; 8(8):718-25. PubMed ID: 1838062
[TBL] [Abstract][Full Text] [Related]
9. Multiple aspects of insulin resistance. Comparison of glucose and intermediary metabolite response to incremental insulin infusion in IDDM subjects of short and long duration.
Singh BM; Palma MA; Nattrass M
Diabetes; 1987 Jun; 36(6):740-8. PubMed ID: 3552803
[TBL] [Abstract][Full Text] [Related]
10. Hormonal and metabolic rhythms in Cushing's syndrome.
Johnston DG; Alberti KG; Nattrass M; Barnes AJ; Bloom SR; Joplin GF
Metabolism; 1980 Oct; 29(11):1046-52. PubMed ID: 7001175
[TBL] [Abstract][Full Text] [Related]
11. The metabolic response to hyperglycaemic clamping in insulin-dependent diabetes.
Nosadini R; Noy GA; Alberti KG; Hodson A; Orskoy H
Diabetologia; 1981 Feb; 20(2):113-7. PubMed ID: 7009290
[TBL] [Abstract][Full Text] [Related]
12. Insulin resistance in multiple aspects of intermediary metabolism in myotonic dystrophy.
Krentz AJ; Williams AC; Nattrass M
Metabolism; 1991 Aug; 40(8):866-72. PubMed ID: 1861635
[TBL] [Abstract][Full Text] [Related]
13. Metabolic effects of low-dose incremental insulin infusion in diabetic man.
Hale PJ; Black E; Nattrass M
Horm Metab Res; 1986 Feb; 18(2):129-33. PubMed ID: 3516823
[TBL] [Abstract][Full Text] [Related]
14. Differences in insulin sensitivity between normal men and women.
Hale PJ; Wright JV; Nattrass M
Metabolism; 1985 Dec; 34(12):1133-8. PubMed ID: 3906353
[TBL] [Abstract][Full Text] [Related]
15. The metabolic and hormonal response to acute normoglycaemia in type 1 (insulin-dependent) diabetes: studies with a glucose controlled insulin infusion system (artificial endocrine pancreas).
Nosadini R; Noy GA; Nattrass M; Alberti KG; Johnston DG; Home PD; Orskov H
Diabetologia; 1982 Sep; 23(3):220-8. PubMed ID: 6751902
[TBL] [Abstract][Full Text] [Related]
16. Insulin resistance in type 1 (insulin-dependent) diabetes: dissimilarities for glucose and intermediary metabolites.
Nijs HG; Radder JK; Poorthuis BJ; Krans HM
Diabetes Res; 1990 Sep; 15(1):15-9. PubMed ID: 2132195
[TBL] [Abstract][Full Text] [Related]
17. Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation.
Dmitrewski J; Krentz AJ; Mayer AD; Buckels JA; Barnes AD; Smith J; Nattrass M
Diabetes Obes Metab; 2001 Aug; 3(4):287-92. PubMed ID: 11520309
[TBL] [Abstract][Full Text] [Related]
18. The effects of subcutaneous human proinsulin on the production of 64/65 split proinsulin, glucose turnover and intermediary metabolism in non-insulin-dependent diabetic man.
Davis SN; Piatti PM; Monti L; Brown M; Hetherington C; Antsiferov M; Sobey W; Hales CN; Orskov H; Alberti KG
Diabetes Res Clin Pract; 1993 Feb; 19(2):103-13. PubMed ID: 8472625
[TBL] [Abstract][Full Text] [Related]
19. Metabolic effects of cyclosporin A and FK 506 in liver transplant recipients.
Krentz AJ; Dousset B; Mayer D; McMaster P; Buckels J; Cramb R; Smith JM; Nattrass M
Diabetes; 1993 Dec; 42(12):1753-9. PubMed ID: 7694879
[TBL] [Abstract][Full Text] [Related]
20. Metabolic effects of monomeric insulin analogues of different receptor affinity.
Robertson DA; Singh BM; Hale PJ; Jensen I; Nattrass M
Diabet Med; 1992 Apr; 9(3):240-6. PubMed ID: 1576805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
